title: Neoral as the initial immunosuppressant in liver transplantation; conversion from Sandimmune to Neoral in stable patients.
authors.affiliation: King Fahad National Guard Hospital, Department of Hepatobiliary Sciences, Riyadh, Kingdom of Saudi Arabia.
authors.forename: A T
authors.initials: AT
authors.lastname: Kizilisik
authors.forename: M
authors.initials: M
authors.lastname: al-Sebayel
authors.forename: C B
authors.initials: CB
authors.lastname: Ramirez
mesh_terms: D000284:Administration, Oral; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D004304:Dosage Forms; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies
chemical_list: D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone